Article ISI SCOPUS
JAMA ONCOLOGY  (2018)

Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer Phase 2 Clinical KEYNOTE-059 Trial

Fuchs, CS; Doi T.; Jang, RW; Muro, K; Satoh, T; Machado M.; Sun, WJ; Jalal, SI; Shah, MA; Metges, JP; Garrido, M; Golan, T; Mandala, M; Wainberg, ZA; Catenacci, DV; et. al.

Más información

Título según WOS: Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer Phase 2 Clinical KEYNOTE-059 Trial
Título según SCOPUS: Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: Phase 2 clinical KEYNOTE-059 trial
Título de la Revista: JAMA ONCOLOGY
Volumen: 4
Número: 5
Editorial: AMER MEDICAL ASSOC
Fecha de publicación: 2018
Idioma: English
DOI:

10.1001/jamaoncol.2018.0013
Notas: ISI, SCOPUS